TGFB2 and hepatocellular carcinoma: For example, RALYL can bind to TGF‐β2 mRNA, decrease the m6A modification of TGF‐β2 mRNA, increase the stability of TGF‐β2 mRNA, and upregulate TGF‐β2 to promote the stemness of HCC cells.5